SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QDEL - Quidel more quick diagnosis
QDEL 27.10-2.2%Nov 4 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bill Ounce who wrote (1648)2/18/2000 10:41:00 AM
From: Bill Ounce  Read Replies (1) of 1693
 
USA Today: Aging boomers sweeten biotech

Nice to be running with the trend for a change.

usatoday.com

Someday, scientists may be able to create self-clipping poodles and
lobsters the size of helicopters. But is that reason enough to invest in
biotechnology?

Not really. There are far better reasons. The best: There are 78 million
baby boomers who aren't getting any younger -- and who will need
health care. Health and biotech funds are up a blistering 17.1% this year,
vs. 1.2% for the average diversified stock fund.

Most of the move has been from small biotech companies, not giant
pharmaceutical companies. Merck, for example, has fallen 17% the past
three months, vs. a feverish 97% gain for the American Stock Exchange
Biotech Index. Why the run-up in biotech?

[...]"Tech investors are discovering
that biotechnology stocks are undervalued," says Andy Summers, biotech
analyst at Invesco. [...]
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext